These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1036090)

  • 1. Use of cell-cycle information in the preparation of drug combinations: results with cytosine arabinoside plus actinomycin D1,2.
    Bhuyan BK; Fraser TJ; Day KJ
    Cancer Treat Rep; 1976 Dec; 60(12):1813-8. PubMed ID: 1036090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial synchronization of L1210 cells by 5-fluorouracil and its use in drug combinations.
    Bhuyan BK; Blowers CL; Neil GL; Bono VH; Day KJ
    Cancer Res; 1977 Sep; 37(9):3204-8. PubMed ID: 560250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.
    Bhuyan BK; Fraser TJ; Day KJ
    Cancer Res; 1977 Apr; 37(4):1057-63. PubMed ID: 139202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effect of cytosine arabinoside and thiopurines.
    Valeriote F; Vietti T; Edelstein M
    Cancer Treat Rep; 1976 Dec; 60(12):1925-34. PubMed ID: 1026347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
    Cadman E; Eiferman F
    J Clin Invest; 1979 Sep; 64(3):788-97. PubMed ID: 288743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer simulation of leukemia therapy: combined pharmacokinetics, intracellular enzyme kinetics, and cell kinetics of the treatment of L1210 leukemia by cytosine arabinoside.
    Lincoln T; Morrison P; Aroesty J; Carter G
    Cancer Treat Rep; 1976 Dec; 60(12):1723-39. PubMed ID: 1026330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical effect of cytosine arabinoside on mouse leukemia cell line L1210 cells.
    Nakayama T; Sakamoto S; Sassa S; Suzuki S; Kudo H; Nagasawa H
    Anticancer Res; 2005; 25(1A):157-60. PubMed ID: 15816533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of cytosine arabinoside resistant cells at low frequency using the bromodeoxyuridine/DNA assay.
    Waldman FM; Dolbeare F; Gray JW
    Cytometry; 1985 Nov; 6(6):657-62. PubMed ID: 4064845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
    Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
    Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
    Momparler RL; Veselý J; Momparler LF; Rivard GE
    Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of leukemia in mice, rats, and humans relating time of humoral stimulation, tumor growth, and clinical response.
    Burke PJ; Karp JE; Vaughan WP
    J Natl Cancer Inst; 1981 Sep; 67(3):529-38. PubMed ID: 6944525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy of mouse leukemia L1210 by 1-beta-D-arabinofuranosylcytosine and 6-[(4-nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine.
    Cass CE; Muzik H; Paterson AR
    Cancer Res; 1975 May; 35(5):1187-93. PubMed ID: 1120308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination effects of Ara-C and 5-fluorodeoxyuridine against leukemia cells in vitro and in mice.
    Rauko P; Bauer W; Horvath Z; Höchtl T; Saiko P; Karl D; Schott H; Fritzer-Szekeres M; Novotny L; Szekeres T
    Anticancer Res; 2003; 23(5A):3841-6. PubMed ID: 14666686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.
    Vadlamudi S; Goldin A
    Cancer Chemother Rep; 1971 Dec; 55(5):547-55. PubMed ID: 5159846
    [No Abstract]   [Full Text] [Related]  

  • 15. Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin.
    Edelstein M; Vietti T; Valeriote F
    Cancer Res; 1974 Feb; 34(2):293-7. PubMed ID: 4810905
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system.
    Raymakers RA; Slocum HK; Minderman H; Malmberg M; Rustum YM
    Exp Hematol; 1993 May; 21(5):602-7. PubMed ID: 8513859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective destruction of cultured tumor cells with uncontrolled nuclear division by cytochalasin B and cytosine arabinoside.
    O'Neill FJ
    Cancer Res; 1975 Nov; 35(11 Pt 1):3111-5. PubMed ID: 1182703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
    Cass CE; Au-Yeung TH
    Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interleukin 3 on cytosine arabinoside-mediated cytotoxicity of leukemic myeloblasts.
    Brach M; Klein H; Platzer E; Mertelsmann R; Herrmann F
    Exp Hematol; 1990 Aug; 18(7):748-53. PubMed ID: 1696204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of L1210 leukemia with 5-azacytidine in combination with vincristine, adriamycin, or beta-cytosine arabinoside.
    Presant CA; Vietti TJ; Valeriote F; Coulter DM
    J Natl Cancer Inst; 1981 Dec; 67(6):1283-8. PubMed ID: 6171666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.